288 related articles for article (PubMed ID: 22276166)
1. Decreased autocrine EGFR signaling in metastatic breast cancer cells inhibits tumor growth in bone and mammary fat pad.
Nickerson NK; Mohammad KS; Gilmore JL; Crismore E; Bruzzaniti A; Guise TA; Foley J
PLoS One; 2012; 7(1):e30255. PubMed ID: 22276166
[TBL] [Abstract][Full Text] [Related]
2. Autocrine-derived epidermal growth factor receptor ligands contribute to recruitment of tumor-associated macrophage and growth of basal breast cancer cells in vivo.
Nickerson NK; Mill CP; Wu HJ; Riese DJ; Foley J
Oncol Res; 2013; 20(7):303-17. PubMed ID: 23879171
[TBL] [Abstract][Full Text] [Related]
3. Amphiregulin-EGFR signaling regulates PTHrP gene expression in breast cancer cells.
Gilmore JL; Scott JA; Bouizar Z; Robling A; Pitfield SE; Riese DJ; Foley J
Breast Cancer Res Treat; 2008 Aug; 110(3):493-505. PubMed ID: 17882547
[TBL] [Abstract][Full Text] [Related]
4. Loss of HSulf-1 expression enhances autocrine signaling mediated by amphiregulin in breast cancer.
Narita K; Chien J; Mullany SA; Staub J; Qian X; Lingle WL; Shridhar V
J Biol Chem; 2007 May; 282(19):14413-20. PubMed ID: 17363371
[TBL] [Abstract][Full Text] [Related]
5. Amphiregulin-EGFR signaling mediates the migration of bone marrow mesenchymal progenitors toward PTH-stimulated osteoblasts and osteocytes.
Zhu J; Siclari VA; Liu F; Spatz JM; Chandra A; Divieti Pajevic P; Qin L
PLoS One; 2012; 7(12):e50099. PubMed ID: 23300521
[TBL] [Abstract][Full Text] [Related]
6. Amphiregulin mediates estrogen, progesterone, and EGFR signaling in the normal rat mammary gland and in hormone-dependent rat mammary cancers.
Kariagina A; Xie J; Leipprandt JR; Haslam SZ
Horm Cancer; 2010 Oct; 1(5):229-44. PubMed ID: 21258428
[TBL] [Abstract][Full Text] [Related]
7. Reconstitution of amphiregulin-epidermal growth factor receptor signaling in lung squamous cell carcinomas activates PTHrP gene expression and contributes to cancer-mediated diseases of the bone.
Gilmore JL; Gonterman RM; Menon K; Lorch G; Riese DJ; Robling A; Foley J
Mol Cancer Res; 2009 Oct; 7(10):1714-28. PubMed ID: 19825997
[TBL] [Abstract][Full Text] [Related]
8. EBP50 inhibits EGF-induced breast cancer cell proliferation by blocking EGFR phosphorylation.
Yao W; Feng D; Bian W; Yang L; Li Y; Yang Z; Xiong Y; Zheng J; Zhai R; He J
Amino Acids; 2012 Nov; 43(5):2027-35. PubMed ID: 22476347
[TBL] [Abstract][Full Text] [Related]
9. Autocrine and juxtacrine effects of amphiregulin on the proliferative, invasive, and migratory properties of normal and neoplastic human mammary epithelial cells.
Willmarth NE; Ethier SP
J Biol Chem; 2006 Dec; 281(49):37728-37. PubMed ID: 17035230
[TBL] [Abstract][Full Text] [Related]
10. TAZ induces growth factor-independent proliferation through activation of EGFR ligand amphiregulin.
Yang N; Morrison CD; Liu P; Miecznikowski J; Bshara W; Han S; Zhu Q; Omilian AR; Li X; Zhang J
Cell Cycle; 2012 Aug; 11(15):2922-30. PubMed ID: 22825057
[TBL] [Abstract][Full Text] [Related]
11. Role of epidermal-growth-factor receptor in tumor progression in transformed human mammary epithelial cells.
Ma L; Gauvillé C; Berthois Y; Degeorges A; Millot G; Martin PM; Calvo F
Int J Cancer; 1998 Sep; 78(1):112-9. PubMed ID: 9724102
[TBL] [Abstract][Full Text] [Related]
12. Amphiregulin as a novel target for breast cancer therapy.
Willmarth NE; Ethier SP
J Mammary Gland Biol Neoplasia; 2008 Jun; 13(2):171-9. PubMed ID: 18437539
[TBL] [Abstract][Full Text] [Related]
13. Autocrine HBEGF expression promotes breast cancer intravasation, metastasis and macrophage-independent invasion in vivo.
Zhou ZN; Sharma VP; Beaty BT; Roh-Johnson M; Peterson EA; Van Rooijen N; Kenny PA; Wiley HS; Condeelis JS; Segall JE
Oncogene; 2014 Jul; 33(29):3784-93. PubMed ID: 24013225
[TBL] [Abstract][Full Text] [Related]
14. EGFR ligands drive multipotential stromal cells to produce multiple growth factors and cytokines via early growth response-1.
Kerpedjieva SS; Kim DS; Barbeau DJ; Tamama K
Stem Cells Dev; 2012 Sep; 21(13):2541-51. PubMed ID: 22316125
[TBL] [Abstract][Full Text] [Related]
15. Non-canonical HIF-2α function drives autonomous breast cancer cell growth via an AREG-EGFR/ErbB4 autocrine loop.
Stiehl DP; Bordoli MR; Abreu-Rodríguez I; Wollenick K; Schraml P; Gradin K; Poellinger L; Kristiansen G; Wenger RH
Oncogene; 2012 May; 31(18):2283-97. PubMed ID: 21927022
[TBL] [Abstract][Full Text] [Related]
16. Amphiregulin: role in mammary gland development and breast cancer.
McBryan J; Howlin J; Napoletano S; Martin F
J Mammary Gland Biol Neoplasia; 2008 Jun; 13(2):159-69. PubMed ID: 18398673
[TBL] [Abstract][Full Text] [Related]
17. Amphiregulin carboxy-terminal domain is required for autocrine keratinocyte growth.
Stoll SW; Johnson JL; Li Y; Rittié L; Elder JT
J Invest Dermatol; 2010 Aug; 130(8):2031-40. PubMed ID: 20428186
[TBL] [Abstract][Full Text] [Related]
18. Validation of HB-EGF and amphiregulin as targets for human cancer therapy.
Yotsumoto F; Yagi H; Suzuki SO; Oki E; Tsujioka H; Hachisuga T; Sonoda K; Kawarabayashi T; Mekada E; Miyamoto S
Biochem Biophys Res Commun; 2008 Jan; 365(3):555-61. PubMed ID: 18023415
[TBL] [Abstract][Full Text] [Related]
19. The ADAM17-amphiregulin-EGFR axis in mammary development and cancer.
Sternlicht MD; Sunnarborg SW
J Mammary Gland Biol Neoplasia; 2008 Jun; 13(2):181-94. PubMed ID: 18470483
[TBL] [Abstract][Full Text] [Related]
20. Metalloproteinase-mediated, context-dependent function of amphiregulin and HB-EGF in human keratinocytes and skin.
Stoll SW; Johnson JL; Bhasin A; Johnston A; Gudjonsson JE; Rittié L; Elder JT
J Invest Dermatol; 2010 Jan; 130(1):295-304. PubMed ID: 19609315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
